PHILADELPHIA — Penn Medicine is now home to one of the first fully accredited Pulmonary Hypertension Care Centers (PHCCs) in the country, with its Pulmonary Hypertension/Pulmonary Vascular Disease Program at Penn Presbyterian Medical Center and the Hospital of the University of Pennsylvania. The Pulmonary Hypertension Association (PHA) just announced its first six accredited programs as part of their efforts to improve overall quality of care and ultimately improve outcomes of patients with pulmonary hypertension (PH), specifically pulmonary arterial hypertension (PAH) — a rare and debilitating disease of the lungs that affects the functioning of the heart and can lead to right heart failure.
PHCC accreditation signifies that a PH program is dedicated to making a proper diagnosis and has the capacity to appropriately and comprehensively manage PH patients according to a set of criteria established by the PHA Scientific Leadership Council — 28 global leaders in the field of pulmonary hypertension. These criteria have also been developed with input from many PH stakeholders including physicians, allied health care professionals, patients and PHA leadership and are considered essential to delivering high-quality care for these complex patients.
“It’s an honor to have Penn’s Pulmonary Hypertension/Pulmonary Vascular Disease Program recognized in this way,” said Steven Kawut, MD, MS, associate professor of Medicine and director of the program, who’s also working with the PHA on a new PH patient registry. “It’s thanks to our extraordinarily talented and dedicated clinicians, researchers and staff that we’ve been able to become an accredited center for the care of patients with PH.”
Penn and the other five PHCCs were vetted by a rigorous process that included a detailed application and a comprehensive site visit, with ultimate adjudication by a committee of more than 20 health professionals with vast experience in caring for PH patients. For more information about the accreditation, visit www.phassociation.org.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $8.6 billion enterprise.
The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $494 million awarded in the 2019 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is powered by a talented and dedicated workforce of more than 43,900 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2019, Penn Medicine provided more than $583 million to benefit our community.